These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 19663274)
1. [Use of determination of the serum carcinoembryonic antigen in oncopulmonology]. Lazarev SM; Reshetov AV; Nikolaev GV; Volgin GN; Nokhrin AV; Kokorin DM Vestn Khir Im I I Grek; 2009; 168(3):21-5. PubMed ID: 19663274 [TBL] [Abstract][Full Text] [Related]
2. [Role of biological tumor markers CEA, Cyfra-21, NSE, TU M2-PK in diagnosis and treatment of lung cancer]. Lazarev SM; Massard Zh; Reshetov AV; Nikolaev GV; Volgin GN; Osipov EV; Lomteva EIu; Nokhrin AV; Kakysheva OE Vestn Khir Im I I Grek; 2010; 169(1):39-43. PubMed ID: 20387605 [TBL] [Abstract][Full Text] [Related]
3. Serum biomarkers facilitate the recognition of early- stage cancer and may guide the selection of surgical candidates: a study of carcinoembryonic antigen and tissue polypeptide antigen in patients with operable non-small cell lung cancer. Buccheri G; Ferrigno D J Thorac Cardiovasc Surg; 2001 Nov; 122(5):891-9. PubMed ID: 11689793 [TBL] [Abstract][Full Text] [Related]
4. Relationship between serum carcinoembryonic antigen level and T status in non-small cell lung cancer. Tomita M; Matsuzaki Y; Shimizu T; Hara M; Ayabe T; Onitsuka T Anticancer Res; 2006; 26(5B):3845-8. PubMed ID: 17094411 [TBL] [Abstract][Full Text] [Related]
5. Pathologic stage I non-small cell lung cancer with high levels of preoperative serum carcinoembryonic antigen: clinicopathologic characteristics and prognosis. Matsuguma H; Nakahara R; Igarashi S; Ishikawa Y; Suzuki H; Miyazawa N; Honjo S; Yokoi K J Thorac Cardiovasc Surg; 2008 Jan; 135(1):44-9. PubMed ID: 18179917 [TBL] [Abstract][Full Text] [Related]
6. Prognostic markers for stage I non-small cell lung cancer. Mizuguchi S; Nishiyama N Lung Cancer; 2008 Feb; 59(2):274-5. PubMed ID: 18055061 [No Abstract] [Full Text] [Related]
7. The prognostic value of carcinoembryonic antigen in T1N1M0 and T2N1M0 non-small cell carcinoma of the lung. Fukai R; Sakao Y; Sakuraba M; Oh S; Shiomi K; Sonobe S; Saitoh Y; Miyamoto H Eur J Cardiothorac Surg; 2007 Sep; 32(3):440-4. PubMed ID: 17643308 [TBL] [Abstract][Full Text] [Related]
8. Serum carcinoembryonic antigen level in pN1 non-small cell lung cancer patients. Tomita M; Matsuzaki Y; Shimizu T; Hara M; Ayabe T; Onitsuka T Anticancer Res; 2005; 25(5):3601-5. PubMed ID: 16101187 [TBL] [Abstract][Full Text] [Related]
9. [Clinical value of combined detection of serum tumor markers in lung cancer diagnosis]. Chen F; Li WM; Wang DM; Gao SS; Bao Y; Chen WB; Liu D Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 39(5):832-5. PubMed ID: 19024326 [TBL] [Abstract][Full Text] [Related]
10. [The function of the level of serum carcinoembryonic antigen on early recurrence of non-small cell lung cancer]. Zhang ZF; Ma JQ; Sun N; Zhang L Zhonghua Wai Ke Za Zhi; 2004 Jul; 42(13):817-9. PubMed ID: 15363304 [TBL] [Abstract][Full Text] [Related]
11. Comparison of serum growth factors and tumor markers as prognostic factors for survival in non-small cell lung cancer. Nieder C; Andratschke N; Jeremic B; Molls M Anticancer Res; 2003; 23(6D):5117-23. PubMed ID: 14981976 [TBL] [Abstract][Full Text] [Related]
12. [Value of tumor markers in monitoring of cytotoxic treatment of non-small cell lung cancer]. Załeska M Pneumonol Alergol Pol; 2003; 71(7-8):359-64. PubMed ID: 15052970 [No Abstract] [Full Text] [Related]
13. Detection of circulating tumor cells in patients with non-small cell lung cancer undergoing lobectomy by video-assisted thoracic surgery: a potential hazard for intraoperative hematogenous tumor cell dissemination. Yamashita JI; Kurusu Y; Fujino N; Saisyoji T; Ogawa M J Thorac Cardiovasc Surg; 2000 May; 119(5):899-905. PubMed ID: 10788810 [TBL] [Abstract][Full Text] [Related]
14. [Value of combined detection of tumor markers for the prediction of small cell and non-small cell lung cancer]. Wu Y; Wu Y; Wang L; Qu L Wei Sheng Yan Jiu; 2000 Jul; 29(4):213-5. PubMed ID: 12520921 [TBL] [Abstract][Full Text] [Related]
15. [The serum concentration of metalloproteinase 9 and 2 in non-small cell lung cancer patients]. Kopczyńska E; Dancewicz M; Kowalewski J; Kardymowicz H; Tyrakowski T Pol Merkur Lekarski; 2007 Jun; 22(132):539-41. PubMed ID: 17874625 [TBL] [Abstract][Full Text] [Related]
16. [Clinical significance of expressions of tumor markers in peripheral blood in non-small cell lung cancer]. Qu YM; Liao GQ; Liu PH; Wang HM; Liu L; Li LL; Xie GQ Zhonghua Yi Xue Za Zhi; 2010 Jul; 90(28):1958-62. PubMed ID: 20979858 [TBL] [Abstract][Full Text] [Related]
17. [The evaluation to relationship between serum vascular endothelial growth factor (VEGF) level, metastases and other tumor markers in patients with lung cancer]. Sağlam DA; Ursavaş A; Karadağ M; Yilmaztepe Oral A; Coşkun F; Gözü RO Tuberk Toraks; 2008; 56(1):50-5. PubMed ID: 18330755 [TBL] [Abstract][Full Text] [Related]
18. Value of tumour and inflammatory markers in lung cancer. Oremek GM; Sauer-Eppel H; Bruzdziak TH Anticancer Res; 2007; 27(4A):1911-5. PubMed ID: 17649794 [TBL] [Abstract][Full Text] [Related]
19. Soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) detection in cancer patients: a prognostic marker for lung metastases from solid malignancies. Karapanagiotou EM; Pelekanou E; Charpidou A; Tsaganos T; Anagnostou V; Plachouras D; Giamarellos-Bourboulis EJ; Syrigos KN Anticancer Res; 2008; 28(2B):1411-5. PubMed ID: 18505088 [TBL] [Abstract][Full Text] [Related]
20. [Comparison and analysis of three classifying models for discrimination of lung cancer established by 6 tumor markers]. Feng F; Nie G; Wu Y; Wu Y Wei Sheng Yan Jiu; 2009 Jul; 38(4):429-32. PubMed ID: 19689074 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]